Bio-Path Holdings, Inc. (BPTH) Financials

BPTH Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 690000 8.7 million
June 30, 2025 746000 7.9 million
March 31, 2025 2.2 million 4.8 million
Dec. 31, 2024 3.9 million 3.7 million

BPTH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 ? 27000
June 30, 2025 -283000 28000
March 31, 2025 -1.3 million 108000
Dec. 31, 2024 -2.9 million 127000

BPTH Net Income

No data available :(

BPTH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 - - 27000
June 30, 2025 - - 57000
March 31, 2025 122000 - 54000
Dec. 31, 2024 1.2 million - 83000

BPTH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 9.2 million
June 30, 2025 8.3 million
March 31, 2025 8.3 million
Dec. 31, 2024 5.8 million

BPTH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 - 275000 213000 -
June 30, 2025 - 4.0 million 514000 -
March 31, 2025 - 2.0 million 1.3 million -
Dec. 31, 2024 - 1.8 million 808000 -

BPTH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 - -
June 30, 2025 - 41000
March 31, 2025 - 32000
Dec. 31, 2024 158000 -

BPTH

Price: $0.04

52 week price:
0.01
0.23

Earnings Per Share: -1.14 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 19400

Ebitda: -4.6 million

Market Capitalization: 373686

Links: